Nanotechnologie oder Microsystemtechnik Fond gesucht
Seite 1 von 1 Neuester Beitrag: 13.04.10 22:15 | ||||
| Eröffnet am: | 13.04.00 12:50 | von: Karlchen | Anzahl Beiträge: | 15 |
| Neuester Beitrag: | 13.04.10 22:15 | von: beatLesvirus | Leser gesamt: | 25.084 |
| Forum: | Börse | Leser heute: | 6 | |
| Bewertet mit: |  | |||
Hi Leute,
kennt einer von euch einen Fond aus den Bereichen Nanotechnologie oder Microsystemtechnik? Gibt es sowas schon?
Einzelne Werte sind mir hier noch zu spekulativ aber das wird sicher DIE Zukunft (jetzt kaufen und in 10 - 15 Jahren in Rente gehen ;-) hihi)
kennt einer von euch einen Fond aus den Bereichen Nanotechnologie oder Microsystemtechnik? Gibt es sowas schon?
Einzelne Werte sind mir hier noch zu spekulativ aber das wird sicher DIE Zukunft (jetzt kaufen und in 10 - 15 Jahren in Rente gehen ;-) hihi)
Hi Karlchen, die Idee ist gut, aber momentan nicht ausführbar.
Das Problem ist, dass die Nanotechnik noch im Strampelanzug steckt. Das sehen manche anders, aber für mich ist die eigentliche Nanotechnik die NANOMECHANIK und nicht die NANOMATERIALIEN. Und nur bei den Materialien gibt es eine handvoll Firmen, an denen man sich über die Börse beteiligen kann - zu wenig, um einen Fonds aufzulegen.
In der Nanomechanik gibts zwar inzwischen auch ein paar vorsichtige Versuche, aus den Forschungslabor in die kommerzielle Umsetzung zu gehen, aber die paar Firmen sind alle noch in der Venture-Capital-Phase.
Aber trotzdem, Augen auf und weiterverfolgen - ich seh die Zukunftsaussichten ähnlich wie Du.
Good trades, Fips
Das Problem ist, dass die Nanotechnik noch im Strampelanzug steckt. Das sehen manche anders, aber für mich ist die eigentliche Nanotechnik die NANOMECHANIK und nicht die NANOMATERIALIEN. Und nur bei den Materialien gibt es eine handvoll Firmen, an denen man sich über die Börse beteiligen kann - zu wenig, um einen Fonds aufzulegen.
In der Nanomechanik gibts zwar inzwischen auch ein paar vorsichtige Versuche, aus den Forschungslabor in die kommerzielle Umsetzung zu gehen, aber die paar Firmen sind alle noch in der Venture-Capital-Phase.
Aber trotzdem, Augen auf und weiterverfolgen - ich seh die Zukunftsaussichten ähnlich wie Du.
Good trades, Fips
Es gibt auch meines Wissens keinen Fond oder Basket-Zertifikat der/das auf Nanotechnologie fokussiert ist. Bestenfalls könnte man einen Fond suchen, der unter anderem Unternehmen der Nanotechnologie umfaßt. daher meine obige Frage.
Gruß furby
Gruß furby
In dem Bericht gings es um Nanotechnologie. Namentlich genannt wurden in dem Bericht Nanophase WKN:910885 und Nanopierce WKN:916132. Nanopierce wurde etwas hervorgehoben, hier im Board steht was über Nanophase. Ich hab beide Unternehmen seit dem Bericht auf meiner Watchlist, ging bei beiden stark abwärts (war ja auch nich schwierig bei dem Umfeld). Einen Fonds hab ich auch noch nich gefunden.
Nanopierce ist doch wohl eher was für die Halbleiterabteilung.
Ich finde, NANOGEN (Biosensoren + Microsystemtechnik), Henkel (Coatings) und Ferrofluidics (sind aber inzwischen aufgekauft worden) auch noch dazu.
Ich finde, NANOGEN (Biosensoren + Microsystemtechnik), Henkel (Coatings) und Ferrofluidics (sind aber inzwischen aufgekauft worden) auch noch dazu.
http://195.88.176.110/cgi-bin/f_anz.pl?board=gesamt&nr=26864&265
ansonsten Nanophase oben eingeben,Altif ist auch interessant
ansonsten Nanophase oben eingeben,Altif ist auch interessant
Monday March 18, 4:29 pm Eastern Time
Harris & Harris Up -2: CEO Cites Nanotech
Interest
By: John Seward, Of DOW JONES NEWSWIRES
NEW YORK -(Dow Jones)- Harris & Harris Group Inc. (HHGP) shares rose 15% to a year high Monday on word that
Credit Suisse First Boston resurfaced as a major shareholder last quarter, and on more reports of insider purchases.
Credit Suisse held 114,628 shares in the venture capital company, according to 13F filings tablulated by Thomson Financial.
But Chairman and Chief Executive Charles E. Harris attributed the market activity to a rising interest in nanotechnology.
Since earlier this year, the company has chosen to invest soley in the development of nanotechnology - sometimes defined as
devices with at least one dimension that is between one and 100 nanometers in size. A nanometer is one- billionth of a meter.
Shares in the company spiked 20% Thursday when the Thomson tabulation was published, and another 7.7% Friday.
On Friday, Harris & Harris closed up nearly 8%.
Harris cited numerous recent media reports on the increasing importance of nanotechnology, including the current editions of
Newsweek and Forbes.
The Newsweek and Forbes stories didn't mention Harris & Harris, the CEO said.
"It's going to be all-pervasive," Harris said. "If you make that your focus, you're going to naturally end up with a diversified
portfolio."
The company's assets as of Dec. 31 equaled $2.75 a share.
Harris & Harris traded recently at $3.58 a share, up 48 cents and surpassing Friday's year-high of $3.30 a share.
-John Seward; Dow Jones Newswires; 201-938-5400
Harris & Harris Up -2: CEO Cites Nanotech
Interest
By: John Seward, Of DOW JONES NEWSWIRES
NEW YORK -(Dow Jones)- Harris & Harris Group Inc. (HHGP) shares rose 15% to a year high Monday on word that
Credit Suisse First Boston resurfaced as a major shareholder last quarter, and on more reports of insider purchases.
Credit Suisse held 114,628 shares in the venture capital company, according to 13F filings tablulated by Thomson Financial.
But Chairman and Chief Executive Charles E. Harris attributed the market activity to a rising interest in nanotechnology.
Since earlier this year, the company has chosen to invest soley in the development of nanotechnology - sometimes defined as
devices with at least one dimension that is between one and 100 nanometers in size. A nanometer is one- billionth of a meter.
Shares in the company spiked 20% Thursday when the Thomson tabulation was published, and another 7.7% Friday.
On Friday, Harris & Harris closed up nearly 8%.
Harris cited numerous recent media reports on the increasing importance of nanotechnology, including the current editions of
Newsweek and Forbes.
The Newsweek and Forbes stories didn't mention Harris & Harris, the CEO said.
"It's going to be all-pervasive," Harris said. "If you make that your focus, you're going to naturally end up with a diversified
portfolio."
The company's assets as of Dec. 31 equaled $2.75 a share.
Harris & Harris traded recently at $3.58 a share, up 48 cents and surpassing Friday's year-high of $3.30 a share.
-John Seward; Dow Jones Newswires; 201-938-5400
oder ist man erst heute auf sie aufmerksam geworden?habs vorhin unter den percent gainers gesehen...congratulations
Anscheinend steigen einige institutionelle Anleger ein und so ganz gräuschlos geht das nicht bei so einem marktengen Wert.
Der Artikel zur Namensänderung:
Harris & Harris Group Proposes Name Change To Small-Technology
Venture Capital, Inc.
TUESDAY, MARCH 26, 2002 3:57 PM
- BusinessWire
NEW YORK, Mar 26, 2002 (BUSINESS WIRE) -- Harris & Harris Group, Inc.
(NASDAQ/NMS SYMBOL: HHGP) announced today that its board of directors will submit to
shareholders for approval at the 2002 Annual Meeting a proposal to change the name of the
Company to Small-Technology Venture Capital, Inc.
The date of the 2002 Annual Meeting has not been set.
The Company's management and board believes that the name, "Small-Technology Venture
Capital, Inc.," now best describes the Company's business. The Company will continue to
function as a publicly traded venture capital firm specializing in early-stage, high technology
companies commercializing proprietary intellectual property. But earlier in 2002, the
Company announced that it will now focus its new business activities exclusively on small
technology (small tech), including nanotechnology, microsystems and
microelectromechanical systems (MEMS).
In 1994, the Company invested in its first small-tech company, Nanophase Technologies
Corporation, a spinoff from Argonne National Laboratory, which subsequently completed an
initial public offering in 1997. The Company sold its interest in Nanophase in 2001 and
invested part of the proceeds of the sale in August, 2001, in privately held Nantero, Inc., a
Harvard University spinoff developing advanced memory devices using carbon nanotubes. In
February, 2002, the Company invested in privately held Nanopharma Corp., a research-based
Massachusetts General Hospital spinoff founded to develop advanced drug delivery systems.
On March 13, 2002, the Company also noted its investment in NEO Photonics Corporation,
a privately held producer of novel materials compositions to enable a unique optical
integration platform. In March, 2002, the Company also elected two new directors to its
board, Dr. Kelly S. Kirkpatrick and Lori D. Pressman, whose professional backgrounds are
particularly well suited to the Company's small-tech focus.
Der Artikel zur Namensänderung:
Harris & Harris Group Proposes Name Change To Small-Technology
Venture Capital, Inc.
TUESDAY, MARCH 26, 2002 3:57 PM
- BusinessWire
NEW YORK, Mar 26, 2002 (BUSINESS WIRE) -- Harris & Harris Group, Inc.
(NASDAQ/NMS SYMBOL: HHGP) announced today that its board of directors will submit to
shareholders for approval at the 2002 Annual Meeting a proposal to change the name of the
Company to Small-Technology Venture Capital, Inc.
The date of the 2002 Annual Meeting has not been set.
The Company's management and board believes that the name, "Small-Technology Venture
Capital, Inc.," now best describes the Company's business. The Company will continue to
function as a publicly traded venture capital firm specializing in early-stage, high technology
companies commercializing proprietary intellectual property. But earlier in 2002, the
Company announced that it will now focus its new business activities exclusively on small
technology (small tech), including nanotechnology, microsystems and
microelectromechanical systems (MEMS).
In 1994, the Company invested in its first small-tech company, Nanophase Technologies
Corporation, a spinoff from Argonne National Laboratory, which subsequently completed an
initial public offering in 1997. The Company sold its interest in Nanophase in 2001 and
invested part of the proceeds of the sale in August, 2001, in privately held Nantero, Inc., a
Harvard University spinoff developing advanced memory devices using carbon nanotubes. In
February, 2002, the Company invested in privately held Nanopharma Corp., a research-based
Massachusetts General Hospital spinoff founded to develop advanced drug delivery systems.
On March 13, 2002, the Company also noted its investment in NEO Photonics Corporation,
a privately held producer of novel materials compositions to enable a unique optical
integration platform. In March, 2002, the Company also elected two new directors to its
board, Dr. Kelly S. Kirkpatrick and Lori D. Pressman, whose professional backgrounds are
particularly well suited to the Company's small-tech focus.
Tuesday April 16, 10:48 am Eastern Time
Press Release
SOURCE: Harris & Harris Group, Inc.
Harris & Harris Group Invests in NanoOpto
NEW YORK--(BUSINESS WIRE)--April 16, 2002--Harris & Harris Group, Inc. (NASDAQ/NMS SYMBOL: TINY -
news) announced today that it has invested $625,000 in privately held NanoOpto Corp. (www.nanoopto.com).
NanoOpto, a New Jersey-based spinout of Princeton University, is applying propriety nano-optics and nano-manufacturing
technology to design and make components for optical networking.
This investment in NanoOpto reflects Harris & Harris Group's recent decision to focus its new business activities exclusively on
small tech, including nanotechnology, microsystems and microelectromechanical systems (MEMS) technology. In 1994, Harris
& Harris Group invested in its first small tech company, Nanophase Technologies Corporation, a spinoff from Argonne
National Laboratory, which completed an initial public offering in 1997. Harris & Harris Group sold its interest in Nanophase in
2001 and invested part of the proceeds of the sale in August, 2001, in privately held Nantero, Inc., a Harvard University
spinoff developing advanced semiconductors using nanotechnology. In February 2002, Harris & Harris Group invested in
NanoPharma Corp., a Massachusetts General Hospital spinoff founded to develop advanced drug delivery systems. On March
13, 2002, Harris & Harris Group noted that it had also invested in NEO Photonics Corporation, a privately held company that
develops patented technology that enables the manufacture of unique nanoscale optical compositions for the
telecommunications industry.
Press Release
SOURCE: Harris & Harris Group, Inc.
Harris & Harris Group Invests in NanoOpto
NEW YORK--(BUSINESS WIRE)--April 16, 2002--Harris & Harris Group, Inc. (NASDAQ/NMS SYMBOL: TINY -
news) announced today that it has invested $625,000 in privately held NanoOpto Corp. (www.nanoopto.com).
NanoOpto, a New Jersey-based spinout of Princeton University, is applying propriety nano-optics and nano-manufacturing
technology to design and make components for optical networking.
This investment in NanoOpto reflects Harris & Harris Group's recent decision to focus its new business activities exclusively on
small tech, including nanotechnology, microsystems and microelectromechanical systems (MEMS) technology. In 1994, Harris
& Harris Group invested in its first small tech company, Nanophase Technologies Corporation, a spinoff from Argonne
National Laboratory, which completed an initial public offering in 1997. Harris & Harris Group sold its interest in Nanophase in
2001 and invested part of the proceeds of the sale in August, 2001, in privately held Nantero, Inc., a Harvard University
spinoff developing advanced semiconductors using nanotechnology. In February 2002, Harris & Harris Group invested in
NanoPharma Corp., a Massachusetts General Hospital spinoff founded to develop advanced drug delivery systems. On March
13, 2002, Harris & Harris Group noted that it had also invested in NEO Photonics Corporation, a privately held company that
develops patented technology that enables the manufacture of unique nanoscale optical compositions for the
telecommunications industry.
SI*nanoCredit Fonds
Das Fondsvermögen wird vorzugsweise in Aktien führender Nanotechnologieunternehmen in Deutschland und den USA angelegt. Über die SI*-Nanotech-Investment-Matrix werden die Investitionen gleichermaßen in Nanotechnologieprodukte, -werkzeuge, -materialien und -industrie verteilt verwaltet. Darüber hinaus kann das Fondsmanagement zusätzlich Chancen in aussichtsreichen Nebenwerten nutzen. Im Mittelpunkt dabei steht die Auswahl attraktiver Einzeltitel (Stock Picking).
http://www.spielberg-investments.de/si_portfolio_de.html
Das Fondsvermögen wird vorzugsweise in Aktien führender Nanotechnologieunternehmen in Deutschland und den USA angelegt. Über die SI*-Nanotech-Investment-Matrix werden die Investitionen gleichermaßen in Nanotechnologieprodukte, -werkzeuge, -materialien und -industrie verteilt verwaltet. Darüber hinaus kann das Fondsmanagement zusätzlich Chancen in aussichtsreichen Nebenwerten nutzen. Im Mittelpunkt dabei steht die Auswahl attraktiver Einzeltitel (Stock Picking).
http://www.spielberg-investments.de/si_portfolio_de.html